phrykt

AbbVie (ABBV) debt: $64.5B

AbbVie had $64.5B of long-term debt on Dec 31, 2025, including the part due within a year, down 3.5% from $66.8B a year earlier.

From AbbVie's filings with the SEC · Read the filing · ABBV stock page

AbbVie debt by year

$76B2021$63.1B2022$59.2B2023$66.8B2024$64.5B2025

#15 of 2,129 US companies by debt · See the full ranking

Year endedDebtChange
Dec 31, 2025$64.5B-3%
Dec 31, 2024$66.8B+13%
Dec 31, 2023$59.2B-6%
Dec 31, 2022$63.1B-17%
Dec 31, 2021$76B–

Debt of similar companies

Companies in the same industry as AbbVie, by SEC industry code, with the closest debt. Each name opens the same page for that company.

CompanyDebt, latest yearYear ended
Pfizer$64.6BDec 31, 2025
AbbVie$64.5BDec 31, 2025
Merck$49BDec 31, 2025
Bristol Myers Squibb$44.8BDec 31, 2025
Johnson & Johnson$41.4BDec 28, 2025
Eli Lilly$40.9BDec 31, 2025
Bausch Health Companies$20.8BDec 31, 2025

Questions and answers

What is AbbVie's debt?

AbbVie had $64.5B of long-term debt on Dec 31, 2025, including the part due within a year, down 3.5% from $66.8B a year earlier.

Numbers as reported in AbbVie's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology